Received: 25 received: R Re Rec Rece BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 : 1 10 1 1 0 0 0
Revised: 22 revised: R Re Rev Revi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 : 1 10 1 1 0 0 0
Accepted: 10 accepted: A Ac Acc Acce BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 : 1 9 1 1 0 0 0
DOI: 10.1002/elps.202200192 doi: D DO DOI DOI: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 :./. 4 10 1 1 0 0 1
R E r R R R R BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 1 1 0 0 1
Taylor dispersion taylor T Ta Tay Tayl BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 no 0 10 1 0 0 0 1
peptide aggregation peptide p pe pep pept BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 9 1 0 0 0 1
Mihai Deleanu mihai M Mi Mih Miha BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 no 0 5 0 0 0 0 1
Jean-François Hernandez jean-françois J Je Jea Jean BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 - 1 10 0 0 0 0 1
Hervé Cottet hervé H He Her Herv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 no 0 5 0 0 0 0 1
Joseph Chamieh joseph J Jo Jos Jose BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 1 no 0 6 0 0 0 0 1
IBMM, Université ibmm, I IB IBM IBMM BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 ,,, 3 10 0 0 0 0 1
ENSCM, Montpellier, enscm, E EN ENS ENSC BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 ,, 2 7 0 0 0 0 1
Correspondence Correspondence correspondence C Co Cor Corr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 3 0 0 0 0 1
Hervé Cottet hervé H He Her Herv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 , 1 8 0 0 0 0 1
IBMM, Université ibmm, I IB IBM IBMM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 ,,, 3 9 0 0 0 0 1
ENSCM, Montpellier, enscm, E EN ENS ENSC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 ,,. 3 7 0 0 0 0 1
Email: herve.cottet@umontpellier.fr email: E Em Ema Emai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 :.@. 4 10 0 0 0 0 1
joseph.chamieh@umontpellier.fr joseph.chamieh@umontpellier.fr joseph.chamieh@umontpellier.fr j jo jos jose BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 1 0 0 1 .@. 3 7 0 0 0 0 1
Colour online: colour C Co Col Colo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 : 1 10 0 0 0 0 1
view Figures view v vi vie view BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 -. 2 6 0 0 0 0 1
Abstract Abstract abstract A Ab Abs Abst BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 10 0 0 0 0 1
The use the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 ,'- 3 10 0 0 0 0 1
ease, to ease, e ea eas ease BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 ,; 2 9 0 0 0 0 1
however, the however, h ho how howe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 , 1 10 0 0 0 0 1
process. In process. p pr pro proc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 .,(-)(-) 8 9 0 0 0 0 1
fluorescein-5-isothiocyanate (FITC), fluorescein-5-isothiocyanate f fl flu fluo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 3 --(),, 6 9 0 0 0 0 1
dispersion analysis dispersion d di dis disp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 -- 2 9 0 0 0 0 1
induced fluorescence induced i in ind indu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 , 1 10 0 0 0 0 1
process. For process. p pr pro proc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ., 2 10 0 0 0 0 1
mixture of mixture m mi mix mixt BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 (). 3 9 0 0 0 0 1
demonstrated that demonstrated d de dem demo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 no 0 9 0 0 0 0 1
behaviour of behaviour b be beh beha BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 (-),(-), 8 10 0 0 0 0 1
observed. It observed. o ob obs obse BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 .(-)(- 6 9 0 0 0 0 1
42) are 42) 4 42 42) 42) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 ),(-) 5 9 0 0 0 0 1
process, and process, p pr pro proc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,, 2 10 0 0 0 0 1
the lifetime the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 10 0 0 0 0 1
confirmed that confirmed c co con conf BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 - 1 9 0 0 0 0 1
major role major m ma maj majo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 6 . 1 10 0 0 0 0 1
K E k K K K K BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 6 no 0 10 0 0 0 0 1
Alzheimer, amyloid alzheimer, A Al Alz Alzh BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 ,,,, 4 10 0 0 0 0 1
1 1 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 7 no 0 1 0 0 0 0 1
INTRODUCTION INTRODUCTION introduction I IN INT INTR BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 10 0 0 0 0 1
Alzheimer's disease alzheimer's A Al Alz Alzh BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 '()- 4 9 0 0 0 0 1
ogy inducing ogy o og ogy ogy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ' 1 10 0 0 0 0 1
in memory in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 7 . 1 9 0 0 0 0 1
Abbreviations: Aβ, abbreviations: A Ab Abb Abbr BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 :,;,';, 7 10 0 1 0 0 1
fluorescein-5-isothiocyanate; LEDIF, fluorescein-5-isothiocyanate; f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 --;,-- 6 9 0 1 0 0 1
fluorescence; nAβ, fluorescence; f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ;,;, 4 9 0 1 0 0 1
peptide; TDA, peptide; p pe pep pept BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ;,. 3 6 0 1 0 0 1
This is this T Th Thi This BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 -,, 3 10 0 1 0 0 1
medium, provided medium, m me med medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,. 2 5 0 1 0 0 1
© 2022 © © © © © BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 8 .-. 3 4 0 1 0 0 1
main hallmarks main m ma mai main BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 9 no 0 9 0 0 0 0 1
(Aβ) plaques (aβ) ( (A (Aβ (Aβ) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 9 () 2 10 0 0 0 0 1
points that points p po poi poin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 10 0 0 0 0 1
the symptoms the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 ( 1 9 0 0 0 0 1
to be to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 )[,][]. 7 9 0 0 0 0 1
In all in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 9 , 1 9 0 0 0 0 1
the aggregation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 . 1 8 0 0 0 0 1
vitro studies vitro v vi vit vitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 9 no 0 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 - 1 9 0 0 0 0 1
centrations (µM centrations c ce cen cent BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 9 () 2 9 0 0 0 0 1
Electrophoresis 2023;44:701-710. electrophoresis E El Ele Elec BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 ;:-. 4 10 0 1 0 0 0
www.electrophoresis-journal.com www.electrophoresis-journal.com www.electrophoresis-journal.com w ww www www. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 .-. 3 9 0 1 0 0 0
701 701 701 7 70 701 701 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 11 no 0 1 0 1 0 0 0
702 702 702 7 70 702 702 BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 0 no 0 10 1 1 0 0 0
DELEANU et deleanu D DE DEL DELE BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 10 1 1 1 1 0
the in the t th the the BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ([]). 5 9 1 0 0 0 1
process of process p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 0 0 0 1
especially at especially e es esp espe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 0 0 0 1
physiological ones. physiological p ph phy phys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,- 3 9 1 0 0 0 1
tive detection tive t ti tiv tive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 - 1 9 1 0 0 0 1
highly desirable highly h hi hig high BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 0 0 0 1
[5]. This [5]. [ [5 [5] [5]. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 []. 3 8 1 0 0 0 1
structure by structure s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -. 2 8 1 0 0 0 1
However, the however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 1 0 0 0 1
chemical properties chemical c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 [] 2 9 1 0 0 0 1
propensity to propensity p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -. 2 9 1 0 0 0 1
Wägele et wägele W Wä Wäg Wäge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 .[],- 5 9 1 0 0 0 1
troscopy (FCS), troscopy t tr tro tros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (),( 4 9 1 0 0 0 1
647, HiLyte 647, 6 64 647 647, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 ,,)- 4 9 1 0 0 0 1
tribution of tribution t tr tri trib BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (-)(-). 7 8 1 0 0 0 1
that HiLyte that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 1 0 0 0 1
tags, had tags, t ta tag tags BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,- 2 8 1 0 0 0 1
the formation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 1 0 0 0 1
of Aβ(1-40) of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (-). 4 8 1 0 0 0 1
this experiment, this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 1 0 0 0 1
as no as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .. 2 8 1 0 0 0 1
[7] demonstrated [7] [ [7 [7] [7] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 []- 3 8 1 0 0 0 1
peptides on peptides p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 -- 2 9 1 0 0 0 1
kinetics or kinetics k ki kin kine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 8 1 0 0 0 1
contrary, Taverna contrary, c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,. 2 9 1 0 0 0 1
(FluoProbes 488 (fluoprobes ( (F (Fl (Flu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ()- 3 8 1 0 0 0 1
amyloid Aβ(1-42) amyloid a am amy amyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (-)(-,-/ 8 8 1 0 0 0 1
N-terminus Asp n-terminus N N- N-t N-te BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 -)[]. 5 9 1 0 0 0 1
another study another a an ano anot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .[], 4 10 1 0 0 0 1
dyes introduced dyes d dy dye dyes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 1 0 0 0 1
esters (BP, esters e es est este BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (,-)( 5 9 1 0 0 0 1
5-(6)-FITC [fluorescein-5-isothiocyanate]) 5-(6)-fitc 5 5- 5-( 5-(6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 -()-[--]). 10 9 1 0 0 0 1
The authors the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 --()-- 6 8 1 0 0 0 1
ited the ited i it ite ited BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 9 1 0 0 0 1
during the during d du dur duri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 1 0 0 0 1
three promoted three t th thr thre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 9 1 0 0 0 1
as a as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 1 0 0 0 1
aggregation was aggregation a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 •. 2 8 1 0 0 0 1
Under these under U Un Und Unde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 1 0 0 0 1
would take would w wo wou woul BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ()[], 5 8 1 0 0 0 1
seems difficult seems s se see seem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 1 0 0 0 1
dyes. In dyes. d dy dye dyes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 8 1 0 0 0 1
process of process p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 1 0 0 0 1
concentrations, one concentrations, c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 1 0 0 0 1
seeds known seeds s se see seed BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 no 0 9 1 0 0 0 1
low concentrations low l lo low low BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 [].,- 5 8 1 0 0 0 1
tides are tides t ti tid tide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 1 0 0 0 1
label is label l la lab labe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 9 1 0 0 0 1
Amyloid peptides amyloid A Am Amy Amyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 8 1 0 0 0 1
most common most m mo mos most BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (-)(-), 7 8 1 0 0 0 1
differ from differ d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 1 0 0 0 1
terminus, making terminus, t te ter term BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,.- 3 8 1 0 0 0 1
isoforms aggregate isoforms i is iso isof BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 [,]. 4 8 1 0 0 0 1
However, in however, H Ho How Howe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 ,, 2 9 1 0 0 0 1
clear how clear c cl cle clea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ., 2 9 1 0 0 0 1
that the that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 9 1 0 0 0 1
were mainly, were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ,, 2 9 1 0 0 0 1
Aβ(1-42) [14], aβ(1-42) A Aβ Aβ( Aβ(1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 (-)[],(-) 9 9 1 0 0 0 1
several-fold higher several-fold s se sev seve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 -(-).- 6 9 1 0 0 0 1
of these of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 10 1 0 0 0 1
decade [15, decade d de dec deca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 [,]. 4 9 1 0 0 0 1
mixing only mixing m mi mix mixi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 9 1 0 0 0 1
the fibrillation, the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 , 1 10 1 0 0 0 1
[16]. But [16]. [ [1 [16 [16] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 []. 3 9 1 0 0 0 1
be formed be b be be be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 [,]. 4 3 1 0 0 0 1
In previous in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 6 ,- 2 8 1 0 0 0 1
lor dispersion lor l lo lor lor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 () 2 9 1 0 0 0 1
process of process p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 (-)(-),- 8 9 1 0 0 0 1
tide solutions tide t ti tid tide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 [,]., 5 9 1 0 0 0 1
of TDA of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 - 1 9 1 0 0 0 1
diode-induced fluorescence diode-induced d di dio diod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 -() 3 9 1 0 0 0 1
the influence the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 - 1 9 1 0 0 0 1
tide aggregation tide t ti tid tide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 no 0 9 1 0 0 0 1
are formed are a ar are are BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 . 1 6 1 0 0 0 1
2 2 2 2 2 2 2 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 8 no 0 0 0 0 0 0 1
MATERIALS AND materials M MA MAT MATE BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
2.1 2.1 2.1 2 2. 2.1 2.1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 . 1 4 0 0 0 0 1
Materials Materials materials M Ma Mat Mate BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
Aβ(1-40) was aβ(1-40) A Aβ Aβ( Aβ(1 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 (-) 3 9 0 0 0 0 1
an Fmoc an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 8 ,[]. 4 10 0 0 0 0 1
Aβ(1-42) (batch aβ(1-42) A Aβ Aβ( Aβ(1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 (-)(,) 6 9 0 0 0 0 1
was purchased was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (,). 4 8 0 0 0 0 1
Both FITC both B Bo Bot Both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 -, 2 9 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 9 0 0 0 0 1
by MALDI-MS by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 -()-- 5 8 0 0 0 0 1
work (4790 work w wo wor work BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (/()(-) 7 9 0 0 0 0 1
tAβ(1-42), respectively). taβ(1-42), t tA tAβ tAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 (-),). 6 9 0 0 0 0 1
and sodium and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 9 0 0 0 0 1
(France). All (france). ( (F (Fr (Fra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (). 3 10 0 0 0 0 1
obtained from obtained o ob obt obta BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (,). 4 8 0 0 0 0 1
2.2 2.2 2.2 2 2. 2.2 2.2 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 10 . 1 1 0 1 0 0 1
Peptide pretreatment peptide P Pe Pep Pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 10 no 0 10 0 1 0 0 1
preparation preparation preparation p pr pre prep BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 no 0 3 0 1 0 0 1
Both native both B Bo Bot Both BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 ()() 4 8 0 1 0 0 1
pretreated independently pretreated p pr pre pret BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 10 no 0 8 0 1 0 0 1
described [13, described d de des desc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 [,]., 5 10 0 1 0 0 1
at a at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 / 1 8 0 1 0 0 1
solution (NH solution s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 (),- 4 8 0 1 0 0 1
ied peptides ied i ie ied ied BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 10 (.(/)(-),.(/) 13 8 0 1 0 0 1
Aβ(1-42)). The aβ(1-42)). A Aβ Aβ( Aβ(1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 10 (-)). 5 9 0 1 0 0 1
10 min 10 1 10 10 10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 10 - 1 8 0 1 0 0 1
dried. The dried. d dr dri drie BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 ., 2 8 0 1 0 0 1
15222683, 2023, 15222683, 1 15 152 1522 BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 2 11 ,,-,://...//./.,[//].(://../--); 32 10 1 0 1 1 0
DELEANU et deleanu D DE DEL DELE BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 10 1 1 1 0 0
703 703 703 7 70 703 703 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 0 no 0 10 1 1 0 0 0
TA B ta T TA TA TA BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 0 () 2 10 1 1 0 0 1
mixed native/tagged mixed m mi mix mixe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 / 1 4 1 1 0 0 1
Peptide quantities peptide P Pe Pep Pept BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 () 2 10 1 1 0 0 1
(proportions) (proportions) (proportions) ( (p (pr (pro BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 () 2 4 1 1 0 0 1
Sample Sample sample S Sa Sam Samp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 0 no 0 10 1 1 0 0 1
nAβ nAβ naβ n nA nAβ nAβ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 5 1 1 0 0 1
(1-40) (1-40) (1-40) ( (1 (1- (1-4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (-) 3 10 1 1 0 0 1
nAβ nAβ naβ n nA nAβ nAβ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 5 1 1 0 0 1
(1-42) (1-42) (1-42) ( (1 (1- (1-4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (-) 3 10 1 1 0 0 1
tAβ tAβ taβ t tA tAβ tAβ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 5 1 1 0 0 1
(1-40) (1-40) (1-40) ( (1 (1- (1-4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (-) 3 10 1 1 0 0 1
tAβ tAβ taβ t tA tAβ tAβ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 5 1 1 0 0 1
(1-42) (1-42) (1-42) ( (1 (1- (1-4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (-) 3 10 1 1 0 0 1
Aβ(1-40) with aβ(1-40) A Aβ Aβ( Aβ(1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (-) 3 10 1 0 0 0 1
tAβ(1-40) tAβ(1-40) taβ(1-40) t tA tAβ tAβ( BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (-) 3 7 1 0 0 0 1
9.3 (93%) 9.3 9 9. 9.3 9.3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 .() 3 10 1 0 0 0 1
0.7 (7%) 0.7 0 0. 0.7 0.7 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 .() 3 9 1 0 0 0 1
Aβ(1-42) with aβ(1-42) A Aβ Aβ( Aβ(1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (-) 3 10 0 0 0 0 1
tAβ(1-42) tAβ(1-42) taβ(1-42) t tA tAβ tAβ( BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (-) 3 7 0 0 0 0 1
9 (90%) 9 9 9 9 9 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 0 () 2 10 0 0 0 0 1
1 (10%) 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 0 () 2 10 0 0 0 0 1
3:1 Aβ(1-40):Aβ(1-42) 3:1 3 3: 3:1 3:1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 :(-):(-).().() 14 10 0 0 0 0 1
3:1 Aβ(1-40):Aβ(1-42) 3:1 3 3: 3:1 3:1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 :(-):(-) 8 10 0 0 0 0 1
with tAβ(1-40) with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 (-) 3 6 0 0 0 0 1
6.8 (68%) 6.8 6 6. 6.8 6.8 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 .().().() 9 10 0 0 0 0 1
3:1 Aβ(1-40):Aβ(1-42) 3:1 3 3: 3:1 3:1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 :(-):(-) 8 10 0 0 0 0 1
with tAβ(1-42) with w wi wit with BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 (-) 3 6 0 0 0 0 1
7.5 (75%) 7.5 7 7. 7.5 7.5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 .().() 6 10 0 0 0 0 1
1 (10%) 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 1 () 2 4 0 0 0 0 1
and lyophilized and a an and and BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 -• 2 10 0 0 0 0 1
use. The use. u us use use. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 .- 2 9 0 0 0 0 1
pared directly pared p pa par pare BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 9 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 1 no 0 9 0 0 0 0 1
peptide concentrations peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 ,. 2 7 0 0 0 0 1
The mixed the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 8 0 0 0 0 1
prepared so prepared p pr pre prep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 9 0 0 0 0 1
tAβ(1-40) or taβ(1-40) t tA tAβ tAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 1 (-)(-). 7 9 0 0 0 0 1
or tagged or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 .(/) 4 9 0 0 0 0 1
NH 4 nh N NH NH NH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 1 , 1 9 0 0 0 0 1
desired combinations desired d de des desi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 , 1 9 0 0 0 0 1
as detailed as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 ., 2 9 0 0 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 9 0 0 0 0 1
samples. The samples. s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 9 0 0 0 0 1
freeze-drying and freeze-drying f fr fre free BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 --•- 4 9 0 0 0 0 1
solved in solved s so sol solv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 . 1 9 0 0 0 0 1
aggregation study. aggregation a ag agg aggr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 . 1 3 0 0 0 0 1
2.3 2.3 2.3 2 2. 2.3 2.3 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 . 1 1 0 0 0 0 1
Study of study S St Stu Stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 10 0 0 0 0 1
dispersion analysis dispersion d di dis disp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 5 0 0 0 0 1
TDA was tda T TD TDA TDA BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 (, 2 8 0 1 0 0 1
Germany) capillary germany) G Ge Ger Germ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 ) 1 9 0 1 0 0 1
silica capillary silica s si sil sili BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 (,), 4 9 0 1 0 0 1
60 cm 60 6 60 60 60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 3 .. 2 9 0 1 0 0 1
at 51.5 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 .. 2 9 0 1 0 0 1
a Zetalif a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 3 3 (,,) 4 9 0 1 0 0 1
with a with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 9 0 1 0 0 1
was conditioned was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 : 1 8 0 1 0 0 1
(30 min) (30 ( (3 (30 (30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 ()(). 5 10 0 1 0 0 1
Between each between B Be Bet Betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 , 1 9 0 1 0 0 1
20 mM 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 3 ..- 3 9 0 1 0 0 1
ples were ples p pl ple ples BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 no 0 9 0 1 0 0 1
the capillary the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 (,), 4 9 0 1 0 0 1
about 6.5 about a ab abo abou BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 ., 2 9 0 1 0 0 1
to the to t to to to BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 8 1 0 0 0 1
UV detection uv U UV UV UV BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 ., 2 8 1 0 0 0 1
tAβ(1-42) samples, taβ(1-42) t tA tAβ tAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 (-),- 5 8 1 0 0 0 1
namically by namically n na nam nami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 , 1 8 1 0 0 0 1
6 mbar, 6 6 6 6 6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 5 ,. 2 8 1 0 0 0 1
to prevent to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 4 1 0 0 0 1
Experiments were experiments E Ex Exp Expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 1 0 0 0 1
of 100 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 9 1 0 0 0 1
set at set s se set set BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 • 1 9 1 0 0 0 1
an external an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 5 no 0 7 1 0 0 0 1
(Germany). The (germany). ( (G (Ge (Ger BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 (). 3 8 1 0 0 0 1
UV with uv U UV UV UV BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 - 1 7 1 0 0 0 1
orescence with orescence o or ore ores BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 . 1 8 1 0 0 0 1
was collected was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 8 1 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 5 .- 2 8 1 0 0 0 1
tion of tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 8 1 0 0 0 1
the obtained the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 1 0 0 0 1
saturating the saturating s sa sat satu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 8 1 0 0 0 1
observed for observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (-)- 4 8 1 0 0 0 1
ence of ence e en enc ence BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 , 1 8 1 0 0 0 1
these samples these t th the thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (-). 4 8 1 0 0 0 1
The mobile the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 1 0 0 0 1
(pH 7.4; (ph ( (p (pH (pH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 (.;•:.-). 9 10 1 0 0 0 1
were first were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 1 0 0 0 1
buffer solution buffer b bu buf buff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (.) 3 8 1 0 0 0 1
of 100 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 1 0 0 0 1
be incubated be b be be be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 •- 2 9 1 0 0 0 1
rousel. The rousel. r ro rou rous BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 . 1 8 1 0 0 0 1
sample (V sample s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 5 ()(-)- 6 9 1 0 0 0 1
ments, and ments, m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 , 1 8 1 0 0 0 1
Aβ(1-40). The aβ(1-40). A Aβ Aβ( Aβ(1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 (-). 4 8 1 0 0 0 1
124 and 124 1 12 124 124 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 5 , 1 8 1 0 0 0 1
sample volume sample s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 5 (. 2 8 1 0 0 0 1
and 1.3 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 .).,, 5 9 1 0 0 0 1
cap was cap c ca cap cap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 8 1 0 0 0 1
recorded using recorded r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 1 0 0 0 1
exported to exported e ex exp expo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 8 1 0 0 0 1
ing. The ing. i in ing ing. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 . 1 8 1 0 0 0 1
the right the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 9 1 0 0 0 1
on the on o on on on BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ,[,]. 5 7 1 0 0 0 1
3 3 3 3 3 3 3 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 10 no 0 0 0 1 0 0 1
RESULTS AND results R RE RES RESU BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
3.1 3.1 3.1 3 3. 3.1 3.1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 1 0 1 0 0 1
Influence of influence I In Inf Infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
concentration concentration concentration c co con conc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 5 0 1 0 0 1
The effect the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 10 0 1 0 0 1
the aggregation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 9 0 1 0 0 1
different tagged different d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 ((-))- 6 9 0 1 0 0 1
ing from ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 3 10 ., 2 9 0 1 0 0 1
total peak total t to tot tota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 , 1 9 0 1 0 0 1
from the from f fr fro from BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 , 1 9 0 1 0 0 1
15222683, 2023, 15222683, 1 15 152 1522 BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 4 11 ,,-,://...//./.,[//].(://../--); 32 10 1 0 1 0 0
704 704 704 7 70 704 704 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 1 1 0 0 0
DELEANU et deleanu D DE DEL DELE BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 . 1 10 1 1 1 0 0
F I f F F F F BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
experiments at experiments e ex exp expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (:) 3 9 1 0 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -():()(-),()(-)(-),() 21 9 1 0 0 0 1
100% nAβ(1-42), 100% 1 10 100 100% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 (-),()(-)(-),()(-)(-)(-),()(-) 30 8 1 0 0 0 1
nAβ(1-42) + naβ(1-42) n nA nAβ nAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 (-)(-)()(-)(-). 15 8 1 0 0 0 1
evolution, by evolution, e ev evo evol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,. 2 10 1 0 0 0 1
proportion of proportion p pr pro prop BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 4 1 0 0 0 1
the case the t th the the BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 (), 3 9 0 0 0 0 1
the wholly the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 (- 2 9 0 0 0 0 1
ple and ple p pl ple ple BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 ), 2 9 0 0 0 0 1
kinetics of kinetics k ki kin kine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 no 0 10 0 0 0 0 1
slow, as slow, s sl slo slow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 ,- 2 9 0 0 0 0 1
gation increase gation g ga gat gati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 []. 3 9 0 0 0 0 1
normalization of normalization n no nor norm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 no 0 9 0 0 0 0 1
for the for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 9 0 0 0 0 1
each peak each e ea eac each BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 9 0 0 0 0 1
t ag t t t t t BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 4 3 . 1 2 0 0 0 0 1
In the in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 3 (..,), 6 9 0 0 0 0 1
the peak the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 9 0 0 0 0 1
incubation. The incubation. i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 ., 2 8 0 0 0 0 1
same 100 same s sa sam same BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 9 0 0 0 0 1
of 90 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 (-)(-), 7 9 0 0 0 0 1
similar kinetics similar s si sim simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 . 1 9 0 0 0 0 1
In addition, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 3 , 1 9 0 0 0 0 1
for the for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 no 0 9 0 0 0 0 1
elution profiles elution e el elu elut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 []. 3 10 0 0 0 0 1
and during and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 , 1 9 0 0 0 0 1
was around was w wa was was BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 .((- 4 9 0 0 0 0 1
42) monomer 42) 4 42 42) 42) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 ), 2 8 0 0 0 0 1
agreement with agreement a ag agr agre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 [,]). 5 9 0 0 0 0 1
about 1 about a ab abo abou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 , 1 9 0 0 0 0 1
0.8 nm, 0.8 0 0. 0.8 0.8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 .,- 3 9 0 0 0 0 1
cent tag cent c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 (, 2 9 0 0 0 0 1
obtained from obtained o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 [] 2 8 0 0 0 0 1
[22] on [22] [ [2 [22 [22] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 []-.). 6 8 0 0 0 0 1
In the in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 7 , 1 9 0 0 0 0 1
t ag t t t t t BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 4 7 .. 2 9 0 0 0 0 1
samples, respectively. samples, s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 ,. 2 8 0 0 0 0 1
very slowly very v ve ver very BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 no 0 8 0 0 0 0 1
(R h (r ( (R (R (R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 7 (.) 3 9 0 0 0 0 1
1 µM 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 4 7 (). 3 9 0 0 0 0 1
possible to possible p po pos poss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 no 0 9 0 0 0 0 1
concentrations and concentrations c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 , 1 10 0 0 0 0 1
not possible not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 no 0 9 0 0 0 0 1
at these at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 no 0 9 0 0 0 0 1
the UV the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 ., 2 9 0 0 0 0 1
in order in i in in in BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 7 , 1 9 0 0 0 0 1
15222683, 2023, 15222683, 1 15 152 1522 BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 10 ,,-,://...//./.,[//].(://../--); 32 10 1 1 1 0 0
DELEANU et deleanu D DE DEL DELE BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 10 1 1 1 0 0
705 705 705 7 70 705 705 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 no 0 10 1 1 0 0 0
F I f F F F F BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 0 no 0 8 1 0 0 0 1
UV analysis: uv U UV UV UV BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 :()(-),():(-):(-)-(-)(-),()(-),()(-) 36 9 1 0 0 0 1
tAβ(1-40), (E) taβ(1-40), t tA tAβ tAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 (-),():(-):(-)-(-)(-)(-),():(-):(-)-(-) 39 8 1 0 0 0 1
nAβ(1-42) + naβ(1-42) n nA nAβ nAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 (-)(-),()(-)(-).: 17 8 1 0 0 0 1
oligomers (squares, oligomers o ol oli olig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (,),(,•)(,).:: 14 9 1 0 0 0 1
total Aβ; total t to tot tota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ;,..:•.:.... 12 9 1 0 0 0 1
Mobile phase: mobile M Mo Mob Mobi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 :,..:.:,(/.). 13 10 1 0 0 0 1
were performed were w we wer were BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 •. 2 3 1 0 0 0 1
important to important i im imp impo BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 , 1 9 0 1 0 0 1
tagged peptides tagged t ta tag tagg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 . 1 8 0 1 0 0 1
In conclusion in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 5 , 1 10 0 1 0 0 1
concentration of concentration c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 8 0 1 0 0 1
study the study s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 - 1 9 0 1 0 0 1
tion process tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 ( 1 9 0 1 0 0 1
instead of instead i in ins inst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 )., 3 9 0 1 0 0 1
combined with combined c co com comb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 () 2 9 0 1 0 0 1
seems hardly seems s se see seem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 9 0 1 0 0 1
aggregation because aggregation a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 , 1 9 0 1 0 0 1
fluorescent tag fluorescent f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 9 0 1 0 0 1
studied on studied s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 , 1 9 0 1 0 0 1
at 100 at a at at at BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 . 1 9 0 1 0 0 1
aggregation kinetics aggregation a ag agg aggr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 , 1 10 0 1 0 0 1
use of use u us use use BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 . 1 10 0 1 0 0 1
3.2 3.2 3.2 3 3. 3.2 3.2 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 . 1 1 0 1 0 0 1
Monitoring the monitoring M Mo Mon Moni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 no 0 10 0 1 0 0 1
of Aβ of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 - 1 7 0 1 0 0 1
In this in I In In In BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 9 , 1 8 0 1 0 0 1
between 7% between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 (), 3 9 0 1 0 0 1
constant the constant c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 . 1 8 0 1 0 0 1
Simultaneous UV simultaneous S Si Sim Simu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 no 0 8 0 1 0 0 1
compared using compared c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 -- 2 8 0 1 0 0 1
tures. The tures. t tu tur ture BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 . 1 10 0 1 0 0 1
15222683, 2023, 15222683, 1 15 152 1522 BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 10 ,,-,://...//./.,[//].(://../--); 32 10 1 0 1 0 0
706 706 706 7 70 706 706 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 0 no 0 10 1 1 0 0 0
DELEANU et deleanu D DE DEL DELE BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 10 1 1 1 0 0
F I f F F F F BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 ( 1 8 1 0 0 0 1
symbols) and symbols) s sy sym symb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 )--()():()(-) 13 8 1 0 0 0 1
tAβ(1-40), (B) taβ(1-40), t tA tAβ tAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 (-),():(-):(-)-(-)(-)(-),():(-):(-)-(-) 39 8 1 0 0 0 1
nAβ(1-42) + naβ(1-42) n nA nAβ nAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 (-)(-)()(-)(-). 15 9 1 0 0 0 1
evolution by evolution e ev evo evol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 10 1 0 0 0 1
proportion of proportion p pr pro prop BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 4 1 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 5 ()() 4 9 1 0 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 --()(-) 7 9 1 0 0 0 1
(squares), 10 (squares), ( (s (sq (squ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 (),()(),(-)(-)(-) 17 9 1 0 0 0 1
(inversed triangles). (inversed ( (i (in (inv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 ().()(. 7 10 1 0 0 0 1
[21]) over [21]) [ [2 [21 [21] BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 [])(-)((-)[](-) 15 9 1 0 0 0 1
10% tAβ(1-42) 10% 1 10 10% 10% BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 (-)[]) 6 2 1 0 0 0 1
15222683, 2023, 15222683, 1 15 152 1522 BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 10 ,,-,://...//./.,[//].(://../--); 32 10 1 1 1 0 0
DELEANU et deleanu D DE DEL DELE BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 10 1 1 1 0 0
707 707 707 7 70 707 707 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 0 no 0 10 1 1 0 0 0
F I f F F F F BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 no 0 8 1 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 9 1 1 0 0 1
graph represents graph g gr gra grap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 8 1 1 0 0 1
(black) fitted (black) ( (b (bl (bla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 () 2 9 1 1 0 0 1
peaks (dashed peaks p pe pea peak BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 () 2 9 1 1 0 0 1
represented on represented r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 9 1 1 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 0 no 0 8 1 1 0 0 1
difference between difference d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
the theoretical the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .: 2 10 1 1 0 0 1
Sample: 100 sample: S Sa Sam Samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 ::(-):(-) 9 8 1 1 0 0 1
mixture (68% mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ((-) 4 6 1 1 0 0 1
tAβ(1-40) + taβ(1-40) t tA tAβ tAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 (-)(-)); 8 9 1 1 0 0 1
20 mM 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 0 ..: 3 9 1 1 0 0 1
quiescent conditions quiescent q qu qui quie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 •. 2 9 1 1 0 0 1
capillaries: 50 capillaries: c ca cap capi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 :.... 5 9 1 1 0 0 1
Mobile phase: mobile M Mo Mob Mobi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 :, 2 8 1 1 0 0 1
7.4. Mobilization 7.4. 7 7. 7.4 7.4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 ..:. 4 8 1 1 0 0 1
Injection: 44 injection: I In Inj Inje BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 :. 2 9 1 1 0 0 1
performed at performed p pe per perf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 •.. 3 9 1 1 0 0 1
Baseline treatment baseline B Ba Bas Base BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 no 0 7 1 1 0 0 1
Microcal Origin. microcal M Mi Mic Micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 9 1 1 0 0 1
the taylorgrams the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
sum of sum s su sum sum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 1 1 0 0 1
Excel. Excel. excel. E Ex Exc Exce BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 1 1 1 0 0 1
of aggregation of o of of of BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 no 0 8 1 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 2 .[], 4 9 1 0 0 0 1
showed by showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 - 1 8 1 0 0 0 1
tion could tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 no 0 9 1 0 0 0 1
by their by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 . 1 9 1 0 0 0 1
and small and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 no 0 8 1 0 0 0 1
R h r R R R R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 2 . 1 8 1 0 0 0 1
molar mass molar m mo mol mola BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 . 1 8 1 0 0 0 1
third population third t th thi thir BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 no 0 8 1 0 0 0 1
soluble protofibrillar soluble s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 . 1 9 1 0 0 0 1
that of that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 . 1 10 1 0 0 0 1
Figure 5 figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 2 no 0 9 1 0 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 no 0 9 1 0 0 0 1
total UV total t to tot tota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 . 1 9 1 0 0 0 1
of Figure of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 ( 1 9 1 0 0 0 1
the theoretical the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 ). 2 9 1 0 0 0 1
In Figure in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 2 no 0 8 1 0 0 0 1
small oligomers small s sm sma smal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 2 no 0 8 1 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 no 0 8 1 0 0 0 1
aggregation process aggregation a ag agg aggr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 .- 2 9 1 0 0 0 1
lution of lution l lu lut luti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 2 no 0 9 1 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 [,] 3 9 1 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 ., 2 8 1 0 0 0 1
nAβ(1-40) showed naβ(1-40) n nA nAβ nAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 (-) 3 9 1 0 0 0 1
decrease in decrease d de dec decr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 no 0 8 1 0 0 0 1
lower plateau lower l lo low lowe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 .(-) 4 9 1 0 0 0 1
secondary nucleation secondary s se sec seco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 , 1 8 1 0 0 0 1
to already to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 , 1 10 1 0 0 0 1
going through going g go goi goin BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 - 1 9 1 0 0 0 1
erature [20, erature e er era erat BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 [,,].,(-)() 11 10 1 0 0 0 1
decreased rapidly decreased d de dec decr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 () 2 9 1 0 0 0 1
lag phase. lag l la lag lag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 .:(-):(-) 9 9 1 0 0 0 1
a similar a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 7 6 (-) 3 8 1 0 0 0 1
slower kinetics slower s sl slo slow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 (). 3 9 1 0 0 0 1
displayed in displayed d di dis disp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ,(-) 4 9 1 0 0 0 1
nAβ(1-40) did naβ(1-40) n nA nAβ nAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 (-);, 5 9 1 0 0 0 1
it affected it i it it it BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 8 1 0 0 0 1
which reached which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 9 1 0 0 0 1
the 100% the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 . 1 9 1 0 0 0 1
the tagged the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 9 1 0 0 0 1
the aggregation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 . 1 9 1 0 0 0 1
When the when W Wh Whe When BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 6 (-)()(-) 8 8 1 0 0 0 1
sample (see sample s sa sam samp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 6 (), 3 9 1 0 0 0 1
decreased as decreased d de dec decr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 9 1 0 0 0 1
plateau changed plateau p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ., 2 10 1 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 6 :(-):(-), 9 9 1 0 0 0 1
7% of 7% 7 7% 7% 7% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 (-), 4 8 1 0 0 0 1
the aggregation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 9 1 0 0 0 1
compared to compared c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ., 2 9 1 0 0 0 1
were observed were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ( 1 9 1 0 0 0 1
of 16 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ; 1 9 1 0 0 0 1
to Figure to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 ).(-) 5 9 1 0 0 0 1
peptide is peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 : 1 9 1 0 0 0 1
formed the formed f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 () 2 9 1 0 0 0 1
was slowed was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 (-)., 5 9 1 0 0 0 1
of tAβ(1-42) of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 (-), 4 9 1 0 0 0 1
mechanism resembled mechanism m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 no 0 8 1 0 0 0 1
Aβ(1-40) solutions, aβ(1-40) A Aβ Aβ( Aβ(1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 6 (-),, 5 10 1 0 0 0 1
15222683, 2023, 15222683, 1 15 152 1522 BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 11 ,,-,://...//./.,[//].(://../--); 32 10 1 1 1 0 0
708 708 708 7 70 708 708 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 no 0 10 1 1 0 0 0
DELEANU et deleanu D DE DEL DELE BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 10 1 1 1 0 0
about 30 about a ab abo abou BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 1 0 0 0 1
decreased until decreased d de dec decr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 1 0 0 0 1
These observations these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 (-) 3 9 1 0 0 0 1
the formation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (-) 3 9 1 0 0 0 1
for the for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (-).. 5 9 1 0 0 0 1
[9], the [9], [ [9 [9] [9], BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 [],, 4 9 1 0 0 0 1
FITC tag fitc F FI FIT FITC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 , 1 8 1 0 0 0 1
of tAβ(1-42) of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (-). 4 8 1 0 0 0 1
concluded that concluded c co con conc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
oligomers to oligomers o ol oli olig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 10 1 0 0 0 1
increase of increase i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
tag. Further, tag. t ta tag tag. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .,(-) 5 9 1 0 0 0 1
and its and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 8 1 0 0 0 1
mations [25], mations m ma mat mati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 [],- 4 8 1 0 0 0 1
water-shielded. In water-shielded. w wa wat wate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -., 3 8 1 0 0 0 1
the hydrophilic-hydrophobic the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -, 2 9 1 0 0 0 1
induce steric induce i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 8 1 0 0 0 1
formation, leading formation, f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,. 2 9 1 0 0 0 1
For instance, for F Fo For For BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 9 1 0 0 0 1
N-terminally truncated n-terminally N N- N-t N-te BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 - 1 9 1 0 0 0 1
to aggregation to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 [-] 3 9 1 0 0 0 1
the truncated the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 8 1 0 0 0 1
which supports which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
N-terminus region n-terminus N N- N-t N-te BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 -. 2 7 1 0 0 0 1
Figure 2 figure F Fi Fig Figu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 1 0 0 0 1
studied samples studied s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 9 1 0 0 0 1
volution of volution v vo vol volu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 9 1 0 0 0 1
molar mass molar m mo mol mola BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .-. 3 8 1 0 0 0 1
was relatively was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 9 1 0 0 0 1
cess (Figure cess c ce ces cess BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (,). 4 8 1 0 0 0 1
study, these study, s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 9 1 0 0 0 1
comprises monomers comprises c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 []. 3 8 1 0 0 0 1
mass oligomer mass m ma mas mass BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 9 1 0 0 0 1
all studied all a al all all BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 1 0 0 0 1
Then the then T Th The Then BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 10 1 0 0 0 1
studied systems. studied s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 1 0 0 0 1
tag did tag t ta tag tag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
when compared when w wh whe when BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 5 1 0 0 0 1
When a when W Wh Whe When BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
population for population p po pop popu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 : 1 9 1 0 0 0 1
peptides (Figure peptides p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (), 3 9 1 0 0 0 1
made: first, made: m ma mad made BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 :,, 3 9 1 0 0 0 1
increased in increased i in inc incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 1 0 0 0 1
after 6 after a af aft afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 1 0 0 0 1
lower plateau lower l lo low lowe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .,(-) 5 9 1 0 0 0 1
did not did d di did did BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
this population, this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 9 1 0 0 0 1
both cases both b bo bot both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ((-))., 7 8 1 0 0 0 1
tAβ(1-42) was taβ(1-42) t tA tAβ tAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 (-),-- 6 9 1 0 0 0 1
tribution extended tribution t tr tri trib BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
reached around reached r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 8 1 0 0 0 1
more stabilized more m mo mor more BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 6 1 0 0 0 1
F I f F F F F BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 6 no 0 8 1 0 0 0 1
oligomer population oligomer o ol oli olig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 no 0 9 1 0 0 0 1
dispersion analysis dispersion d di dis disp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 (): 3 7 1 0 0 0 1
Aβ(1-40):Aβ(1-42) -75% aβ(1-40):aβ(1-42) A Aβ Aβ( Aβ(1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 (-):(-)-(-)(-)();: 18 9 1 0 0 0 1
Aβ(1-40):Aβ(1-42) -68% aβ(1-40):aβ(1-42) A Aβ Aβ( Aβ(1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 (-):(-)-(-)(-) 14 7 1 0 0 0 1
nAβ(1-42) (circles); naβ(1-42) n nA nAβ nAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 (-)();:(-):(-)- 15 7 1 0 0 0 1
nAβ(1-40) + naβ(1-40) n nA nAβ nAβ( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 (-)(-)(-)(). 12 9 1 0 0 0 1
was normalized, was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 , 1 8 1 0 0 0 1
evolution, by evolution, e ev evo evol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 , 1 10 1 0 0 0 1
area obtained area a ar are area BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 . 1 6 1 0 0 0 1
The comparison the T Th The The BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 8 no 0 8 0 0 0 0 1
small oligomer small s sm sma smal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 8 ,- 2 9 0 0 0 0 1
files from files f fi fil file BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 (), 3 9 0 0 0 0 1
showed no showed s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 no 0 9 0 0 0 0 1
peptide (selectively peptide p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 8 ()- 3 9 0 0 0 0 1
tides (detected tides t ti tid tide BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 (;- 3 9 0 0 0 0 1
peptides), suggesting peptides), p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 8 ), 2 9 0 0 0 0 1
different peptides different d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 - 1 9 0 0 0 0 1
blies might blies b bl bli blie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 8 ((-) 4 9 0 0 0 0 1
Aβ(1-42)). Figure aβ(1-42)). A Aβ Aβ( Aβ(1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 (-)). 5 9 0 0 0 0 1
decrease of decrease d de dec decr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 (-) 3 9 0 0 0 0 1
incubation, probably incubation, i in inc incu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 , 1 9 0 0 0 0 1
nucleus, followed nucleus, n nu nuc nucl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 ,., 3 9 0 0 0 0 1
the tAβ(1-42) the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 (-)- 4 9 0 0 0 0 1
ing the ing i in ing ing BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 8 8 no 0 10 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 (-)() 5 8 0 0 0 0 1
where the where w wh whe wher BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 no 0 8 0 0 0 0 1
observed as observed o ob obs obse BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 . 1 2 0 0 0 0 1
4 4 4 4 4 4 4 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 9 10 no 0 1 0 1 0 0 1
CONCLUSION CONCLUSION conclusion C CO CON CONC BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 9 10 no 0 10 0 1 0 0 1
In this in I In In In BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 10 , 1 9 0 1 0 0 1
the aggregation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 - 1 9 0 1 0 0 1
orescence detection orescence o or ore ores BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 no 0 9 0 1 0 0 1
on the on o on on on BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 . 1 10 0 1 0 0 1
15222683, 2023, 15222683, 1 15 152 1522 BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 11 ,,-,://...//./.,[//].(://../--); 32 10 1 0 1 0 0
DELEANU et deleanu D DE DEL DELE BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 10 1 1 1 0 0
709 709 709 7 70 709 709 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 no 0 10 1 1 0 0 0
found that found f fo fou foun BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (), 3 9 1 0 0 0 1
the aggregation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 1 0 0 0 1
the monitoring the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 1 0 0 0 1
would be would w wo wou woul BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (). 3 8 1 0 0 0 1
the kinetics the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ,- 2 8 1 0 0 0 1
centration was centration c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 8 1 0 0 0 1
proportion of proportion p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -.- 3 9 1 0 0 0 1
tration, it tration, t tr tra trat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 , 1 9 1 0 0 0 1
of Aβ of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 1 0 0 0 1
Further, it further, F Fu Fur Furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ,(-) 4 9 1 0 0 0 1
and Aβ(1-42) and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (-) 3 9 1 0 0 0 1
label. The label. l la lab labe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 1 0 0 0 1
the elongation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 1 0 0 0 1
Further, in further, F Fu Fur Furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ,(-):(-), 9 9 1 0 0 0 1
the tagged the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (-), 4 9 1 0 0 0 1
influence of influence i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 1 0 0 0 1
than with than t th tha than BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (-)., 5 8 1 0 0 0 1
oligomers in oligomers o ol oli olig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 (-):(-)( 8 9 1 0 0 0 1
proportion of proportion p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (-)) 4 10 1 0 0 0 1
lifetime and lifetime l li lif life BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .,- 3 10 1 0 0 0 1
parison of parison p pa par pari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 9 1 0 0 0 1
the aggregation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 8 1 0 0 0 1
cess involving cess c ce ces cess BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 9 1 0 0 0 1
untagged peptides untagged u un unt unta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ., 2 9 1 0 0 0 1
study of study s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 1 0 0 0 1
the truncation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 , 1 9 1 0 0 0 1
speciated by speciated s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 8 1 0 0 0 1
huge amount huge h hu hug huge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 9 1 0 0 0 1
amyloid peptides. amyloid a am amy amyl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 2 1 0 0 0 1
A C a A A A A BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 9 2 no 0 5 0 0 0 0 1
The authors the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 .(- 3 9 0 0 0 0 1
pellier) for pellier) p pe pel pell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 ) 1 10 0 0 0 0 1
work. work. work. w wo wor work BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 . 1 0 0 0 0 0 1
Open access open O Op Ope Open BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 . 1 6 0 0 0 0 1
C O c C C C C BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 3 no 0 7 0 0 0 0 1
The authors the T Th The The BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 . 1 10 0 0 0 0 1
D ATA d D D D D BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 3 no 0 7 0 1 0 0 1
The data the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 9 0 1 0 0 1
available from available a av ava avai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 no 0 10 0 1 0 0 1
request. request. request. r re req requ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 . 1 1 0 1 0 0 1
O R o O O O O BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 4 no 0 1 0 1 0 0 1
Hervé Cottet hervé H He Her Herv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 4 ://./--- 8 9 0 1 0 0 1
Joseph Chamieh joseph J Jo Jos Jose BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 4 ://./--- 8 10 0 1 0 0 1
R E r R R R R BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 4 no 0 10 0 1 0 0 1
1. Selkoe 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,.' 4 9 0 1 0 0 1
disease at disease d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ..;():-. 8 8 0 1 0 0 1
2. Lambert 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,,,, 6 8 0 1 0 0 1
Liosatos M, liosatos L Li Lio Lios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,., 3 10 0 1 0 0 1
Aβ 1-42 aβ A Aβ Aβ Aβ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 -. 2 9 1 0 0 0 1
Acad Sci acad A Ac Aca Acad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 .;():-. 7 5 1 0 0 0 1
3. Hardy 3. 3 3. 3. 3. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,.': 5 10 1 0 0 0 1
hypothesis. Science. hypothesis. h hy hyp hypo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ..;():-. 8 6 1 0 0 0 1
4. Lazarevic 4. 4 4. 4. 4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,-,,, 7 9 1 0 0 0 1
Montenegro-Venegas C, montenegro-venegas M Mo Mon Mont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 -,. 3 9 1 0 0 0 1
amyloid beta amyloid a am amy amyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 no 0 9 1 0 0 0 1
acetylcholine receptor acetylcholine a ac ace acet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 /. 2 9 1 0 0 0 1
Mol Neurosci. mol M Mo Mol Mol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 .;:. 4 4 1 0 0 0 1
5. Rice 5. 5 5. 5. 5. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,.: 5 10 1 0 0 0 1
fluorescence-based single-molecule fluorescence-based f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 --. 3 9 1 0 0 0 1
Biotechnol J. biotechnol B Bi Bio Biot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 .;:-. 5 4 1 0 0 0 1
6. Wägele 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,,,.- 7 9 1 0 0 0 1
cent tags cent c ce cen cent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 no 0 9 1 0 0 0 1
peptide. Biophys peptide. p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 ..;():-. 8 6 1 0 0 0 1
7. Quinn 7. 7 7. 7. 7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,,, 5 8 1 0 0 0 1
C, Lucocq c, C C, C, C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,,.--- 6 8 1 0 0 0 1
assembly and assembly a as ass asse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 - 1 8 1 0 0 0 1
between neighbouring between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ..;():-. 8 8 1 0 0 0 1
8. Taverna 8. 8 8. 8. 8. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,,.- 6 9 1 0 0 0 1
tors; Méthode tors; t to tor tors BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 ;'. 3 8 1 0 0 0 1
FR3095520A1. 2019. fr3095520a1. F FR FR3 FR30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .. 2 2 1 0 0 0 1
9. Zheng 9. 9 9. 9. 9. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,,,,,. 8 8 1 0 0 0 1
effects of effects e ef eff effe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 - 1 10 1 0 0 0 1
orescence correlation orescence o or ore ores BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 ..;(): 6 9 1 0 0 0 1
e23237. e23237. e23237. e e2 e23 e232 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 4 . 1 1 1 0 0 0 1
10. Hu 10. 1 10 10. 10. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,,,,-. 8 9 1 0 0 0 1
seeds formed seeds s se see seed BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 10 4 ,,- 3 9 1 0 0 0 1
tion of tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 -.. 3 8 1 0 0 0 1
2009;106(48):20324-9. 2009;106(48):20324-9. 2009;106(48):20324-9. 2 20 200 2009 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 4 ;():-. 6 3 1 0 0 0 1
11. Sowade 11. 1 11 11. 11. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,.-- 5 9 1 0 0 0 1
mediated neurotoxicity mediated m me med medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ..;():. 7 8 1 0 0 0 1
12. Wang 12. 1 12 12. 12. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,. 4 8 1 0 0 0 1
and structures and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 .. 2 8 1 0 0 0 1
2021;11(2):198. 2021;11(2):198. 2021;11(2):198. 2 20 202 2021 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 4 ;():. 5 2 1 0 0 0 1
13. Deleanu 13. 1 13 13. 13. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,,,, 6 9 1 0 0 0 1
Taverna M, taverna T Ta Tav Tave BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,.- 3 9 1 0 0 0 1
peptides during peptides p pe pep pept BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 no 0 9 1 0 0 0 1
analysis. Anal analysis. a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ..;():-. 8 6 1 0 0 0 1
14. Roher 14. 1 14 14. 14. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,,,, 6 9 1 0 0 0 1
E, et e, E E, E, E, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,.--(-)- 8 8 1 0 0 0 1
brovascular amyloid brovascular b br bro brov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 : 1 9 1 0 0 0 1
Alzheimer disease. alzheimer A Al Alz Alzh BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ..;():- 7 9 1 0 0 0 1
40. 40. 40. 4 40 40. 40. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 . 1 0 1 0 0 0 1
15. Jan 15. 1 15 15. 15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,-,. 6 9 1 0 0 0 1
monomeric to monomeric m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 no 0 8 1 0 0 0 1
important determinant important i im imp impo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 -,- 3 9 1 0 0 0 1
nesis, and nesis, n ne nes nesi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 ,..;():-. 9 8 1 0 0 0 1
16. Cukalevski 16. 1 16 16. 16. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,,,, 6 9 1 0 0 0 1
B, et b, B B, B, B, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,.- 3 9 1 0 0 0 1
homomolecular fibrils homomolecular h ho hom homo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 - 1 9 1 0 0 0 1
primary nucleation. primary p pr pri prim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ..;():-. 8 7 1 0 0 0 1
17. Cerofolini 17. 1 17 17. 17. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,,, 5 9 1 0 0 0 1
A, Purfürst a, A A, A, A, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 ,,.(-)(-) 9 9 1 0 0 0 1
generates unique generates g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 ..;():-. 8 9 1 0 0 0 1
18. Deleanu 18. 1 18 18. 18. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .,,,-, 6 9 1 0 0 0 1
C, Cottet c, C C, C, C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ,,. 3 9 1 0 0 0 1
microscopy provide microscopy m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 no 0 9 1 0 0 0 1
kinetics of kinetics k ki kin kine BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 4 (-)/(-). 8 9 1 0 0 0 1
Chem Neurosci. chem C Ch Che Chem BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 .;():-. 7 5 1 0 0 0 1
15222683, 2023, 15222683, 1 15 152 1522 BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 11 ,,-,://...//./.,[//].(://../--); 32 10 1 0 1 0 0
710 710 710 7 71 710 710 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 no 0 10 1 1 0 0 0
DELEANU et deleanu D DE DEL DELE BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 . 1 10 1 1 1 0 0
19. Brinet 19. 1 19 19. 19. BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,, 6 8 1 0 0 0 1
M. An m. M M. M. M. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 . 1 8 1 0 0 0 1
monitoring of monitoring m mo mon moni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 (-) 3 8 1 0 0 0 1
oligomerization: application oligomerization: o ol oli olig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 :-'. 4 9 1 0 0 0 1
Electrophoresis. 2014;35(23):3302-9. electrophoresis. E El Ele Elec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .;():-. 7 5 1 0 0 0 1
20. Lattanzi 20. 2 20 20. 20. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,. 6 10 1 0 0 0 1
Aβ40 peptide. aβ40 A Aβ Aβ4 Aβ40 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ..;:. 5 7 1 0 0 0 1
21. Chamieh 21. 2 21 21. 21. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.- 4 9 1 0 0 0 1
tion points tion t ti tio tion BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 no 0 8 1 0 0 0 1
polydisperse samples. polydisperse p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ..;:-. 6 7 1 0 0 0 1
22. Ortega 22. 2 22 22. 22. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,.- 5 9 1 0 0 0 1
dynamic and dynamic d dy dyn dyna BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 8 1 0 0 0 1
atomic-and residue-level atomic-and a at ato atom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 --..;():-. 10 9 1 0 0 0 1
23. Arosio 23. 2 23 23. 23. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,. 4 9 1 0 0 0 1
fibril formation. fibril f fi fib fibr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ..;():-. 8 8 1 0 0 0 1
24. Chen 24. 2 24 24. 24. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .-,. 4 9 1 0 0 0 1
properties of properties p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -. 2 8 1 0 0 0 1
Biol Chem. biol B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .;():-. 7 4 1 0 0 0 1
25. Barz 25. 2 25 25. 25. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,.- 5 8 1 0 0 0 1
of amyloid of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -(-).. 6 7 1 0 0 0 1
2021;57(7):947-50. 2021;57(7):947-50. 2021;57(7):947-50. 2 20 202 2021 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 ;():-. 6 2 1 0 0 0 1
26. Dunys 26. 2 26 26. 26. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,.-- 6 8 1 0 0 0 1
truncated Aβ truncated t tr tru trun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ' 1 8 1 0 0 0 1
disease? J disease? d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ?.;():-. 8 6 1 0 0 0 1
27. Bouter 27. 2 27 27. 27. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,-,, 7 9 1 0 0 0 1
Papot-Couturier S, papot-couturier P Pa Pap Papo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 -,.-()- 7 9 1 0 0 0 1
stable aggregates stable s st sta stab BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 - 1 9 1 0 0 0 1
deficits. Acta deficits. d de def defi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ..;():-. 8 7 1 0 0 0 1
28. Rostagno 28. 2 28 28. 28. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,.-- 7 10 1 0 0 0 1
cated Aβ4-x cated c ca cat cate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 -' 2 9 1 0 0 0 1
pathophysiology. Transl pathophysiology. p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ..;():. 7 8 1 0 0 0 1
29. Bayer 29. 2 29 29. 29. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 ..-- 4 8 1 0 0 0 1
biochemical features, biochemical b bi bio bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ,, 2 9 1 0 0 0 1
drug target drug d dr dru drug BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 '.. 3 8 1 0 0 0 1
2021;13:710579. 2021;13:710579. 2021;13:710579. 2 20 202 2021 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ;:. 3 2 1 0 0 0 1
S U s S S S S BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 8 no 0 7 0 0 0 0 1
Additional supporting additional A Ad Add Addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 no 0 9 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 8 no 0 10 0 0 0 0 1
article. article. article. a ar art arti BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 . 1 1 0 0 0 0 1
How to how H Ho How How BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 9 :, 2 8 0 1 0 0 1
J-F, Cottet j-f, J J- J-F J-F, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 9 -,,. 4 10 0 1 0 0 1
discloses the discloses d di dis disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 no 0 9 0 1 0 0 1
by the by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 . 1 7 0 1 0 0 1
Electrophoresis. 2023;44:701-710. electrophoresis. E El Ele Elec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 9 .;:-. 5 6 0 1 0 0 1
https://doi.org/10.1002/elps.202200192 https://doi.org/10.1002/elps.202200192 https://doi.org/10.1002/elps.202200192 h ht htt http BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 11 9 ://././. 8 7 0 1 0 0 1
15222683, 2023, 15222683, 1 15 152 1522 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 10 ,,-,://...//./.,[//].(://../--); 32 10 1 0 1 0 0

